VICTORY CAPITAL MANAGEMENT INC

Position in APGE — Apogee Therapeutics, Inc.

CIK 1040188 San Antonio, TX

Position in APGE

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$11,674,001

+$3,666,320 QoQ

Shares Held

87,953

-7.6% QoQ

Ownership

0.116%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#80

of 285 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. APGE ranks #24 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,173,152	$1,079,469,792
2	RPRX	Royalty Pharma plc	3,682,932	$206,501,997
3	INCY	Incyte Corp	1,480,342	$167,811,569
4	JAZZ	Jazz Pharmaceuticals plc	686,719	$165,478,677
5	LGND	Ligand Pharmaceuticals Inc	253,764	$80,212,262
6	REGN	Regeneron Pharmaceuticals, Inc.	126,343	$78,779,914
7	ALNY	Alnylam Pharmaceuticals, Inc.	172,842	$52,030,627
8	BNTX	BioNTech SE	539,787	$50,227,180

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,674,001	87,953	-7.6%	Shares	Sole	2026-08-07
2026-03-31	$8,007,681	95,137	-12.1%	Shares	Sole	2026-05-15
2025-12-31	$8,171,993	108,267	-50.2%	Shares	Sole	2026-02-13
2025-09-30	$8,629,872	217,213	-14.7%	Shares	Sole	2025-11-12
2025-06-30	$11,064,660	254,770	+9.4%	Shares	Sole	2025-08-13
2025-03-31	$8,704,244	232,983	+4.4%	Shares	Sole	2025-05-02
2024-12-31	$10,104,708	223,062	-35.6%	Shares	Other	2025-02-06
2024-09-30	$20,345,068	346,358	+121.6%	Shares	Other	2024-11-05
2024-06-30	$6,149,066	156,266	+56.8%	Shares	Sole	2024-08-05
2024-03-31	$6,622,340	99,659	+530.0%	Shares	Other	2024-05-03
2023-12-31	$442,010	15,820	0.0%	Shares	Sole	2024-02-05
2023-09-30	$336,966	15,820	—	Shares	Sole	2023-11-06
No filing history on record for this holder in this stock.